Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges with Dedicated Psychedelic Research Groups
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

PSIPET Research Group

Karolinska Institute, Sweden

The PSIPET study at Karolinska Institute is the first Phase II randomized clinical trial in Sweden investigating psilocybin for depression. The research utilizes PET and MRI imaging to examine synaptic density and the biological mechanisms underlying psilocybin's therapeutic effects.

Academic Research

0 papers

Published Papers

0

Trial Involvement

0

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
academic
HQ
Karolinska Institute, Sweden
Website
Visit